| Action: SELL |
| LSX Code: 963274140 |
| Date: 2013-03-24 22:29:46 |
| Description: eedle retractable safety syringe will replace regular syringes soon, due to its function to avoid blood transmitted diseases from healthcare and other settings. |
| Type: patent |
| Patent Status: Granted |
| Read More |
|
| Action: SELL |
| LSX Code: 1909047063 |
| Date: 2012-12-18 08:07:15 |
| Description: The present invention relates to compounds having general formula (I), i.e. poly- alkyl -bis -maltolic molecules and in particular to derivates of [ (3 -hydroxy- 4 -pyron- 2 -yl) methyl] -amine and pharmaceutically acceptable salts thereof, and to the use thereof as anti -neoplastic drugs, in particular, for the preparation of a medicament for the treatment of neoplastic diseases. |
| Type: patent |
| Patent Status: National Phase |
| Read More |
|
| Action: SELL |
| LSX Code: 857691555 |
| Date: 2012-08-10 03:52:40 |
| Description: Recombinant Herpes Simplex Virus (HSV) Vaccine protects from HSV infections |
| Type: patent |
| Patent Status: Priority filing only |
| Read More |
|
| Action: SELL |
| LSX Code: 1965290621 |
| Date: 2012-08-10 03:11:01 |
| Description: Native Tat, when administered to patients with HIV infection, or who are otherwise immunocompromised, is capable of restoring immune functions so as to recognise recall antigens, and to inhibit replication and key signs of HIV disease and other persistent infections and/or their progression. |
| Type: patent |
| Patent Status: PCT Application |
| Read More |
|
